N. Bradley Keele – Psychopharmacology Update: Medications, the Brain, and Behavior

Salepage : N. Bradley Keele – Psychopharmacology Update: Medications, the Brain, and Behavior
Archive : N. Bradley Keele – Psychopharmacology Update: Medications, the Brain, and Behavior Digital Download
Delivery : Digital Download Immediately

N. Bradley Keele, Professor
6 hours and 16 minutes.
Audio and video formats are available.
Date of publication: April 17, 2020
Description

Is this anything you’ve heard before? Your customers are using a variety of psychotropic drugs that have been recommended by various healthcare specialists. You learn that they have no idea who wrote which prescription or why they are taking the drug in the first place. Despite the uncertainty, you recognize that you still have a responsibility to know your client’s symptoms, responses to drugs, and to coordinate their treatment. It is more important than ever for mental health providers to understand how psychotropic medicines operate, where they function in the body, and why they enhance (or do not improve) your client’s therapy results.

Are you confident in your ability to handle medication-assisted therapies in your overall care plan as both a patient advocate and a protector?

Don’t pass up your chance to learn from an expert in this recording.

N. Bradley Keele, Ph.D., has over 20 years of research expertise in psychopharmacology and teaches clinical neuroscience and psychopharmacology at Baylor University. He will walk you through the most recent developments and current trends in combining pharmaceutical management with psychotherapy interventions for anxiety, PTSD, depression, psychotic disorders, and other conditions. You’ll leave knowing how to answer clients’ inquiries, manage side effects, analyze pharmaceutical responses, and enhance your treatment success.

Handouts

Psychopharmacology Update Manual (9 MB)

Outline 62 Pages Available After Purchase

Psychiatric Precision Medicine

Why we need evidence-based precision medicine
Endophenotypes and biomarkers in the classification and understanding of mental illness
The framework for Research Domain Criteria (RDoC)
Psychopharmacology’s Future

Psychopharmacology’s “Nuts and Bolts”

Mechanisms of administration, distribution, and elimination in pharmacokinetics
Pharmacodynamics
Drug potency and effectiveness, as well as receptor affinity

Neuroanatomy of Function

Prefrontal cortex and subcortical circuit control
Emotional systems with positive and negative valence
The hypothalamus and stress hormone regulation
Neurotransmission: Psychoactive Substance Targets
Synthesis, release, receptors, and inactivation are all involved.

Anxiolytics and Other Anti-Anxiety Medications

Anxiety-related neurotransmitter systems
Anxiety-relieving medications
Non-benzodiazepines and benzodiazepines
The benefits and drawbacks of taking benzodiazepines
Long-term benzodiazepine usage is being discontinued.
Anxiety and medical marijuana
Children/adolescents, pregnant women are examples of special groups.

Medications for Depression

The biochemical foundation of serious depression
The neurotropic theory
The primary antidepressant drug classes
Mechanisms of action and adverse consequences
The five most recent antidepressants
Ketamine and other psychedelics are emerging pharmacotherapies.
Medical marijuana and serious depression
Antidepressant selection and augmentation techniques
A cost-benefit review of antidepressant usage in children and adolescents
Pregnancy and antidepressants

Atypical Antipsychotic Use in Psychosis and Bipolar Disorder

Schizophrenia pathophysiology
What distinguishes an atypical antipsychotic?
Atypical antipsychotics’ mode of action
Side effects and therapeutic effects
Atypical antipsychotics are used to treat schizophrenia and bipolar disorder.
Children/adolescents, pregnant women are examples of special groups.
Faculty
Dr. N. Bradley Keele Seminars and goods related to this topic: 2
Baylor College of Medicine

N. Bradley (Brad) Keele, Ph.D., is the Associate Chair of Baylor University’s Department of Psychology & Neuroscience. He has almost 20 years of expertise teaching both graduate and undergraduate students about psychopharmacology. He was a postdoctoral associate at the National Institutes of Health in Bethesda, MD, before joining Baylor in 1998.

Brad specializes on the neuroscience of complicated emotional behaviors such as anxiety and sadness. With NIH funding, his lab investigates the pharmacological and physiological factors underlying emotional behavior and psychopathology. He has over 25 peer-reviewed primary research publications and book chapters to his credit, and he has spoken at over a dozen national scientific events. Brad received a B.S. in psychology from Baylor University and a Ph.D. in neuroscience from the University of Texas Medical Branch in Galveston.

Brad is a vibrant and engaging speaker who combines research findings with real-world experiences. His audience (particularly his pupils) value his natural ability to deliver psychopharmacology in an approachable and practical manner. Brad is dedicated about offering practical, easy-to-understand information to behavioral health care practitioners in order to improve the lives of those living with mental health issues.

Disclosures for Speakers:

N. Bradley Keele works as an associate professor at Baylor University. PESI, Inc. pays him a speaking honorarium.

N. Bradley Keele does not have any relevant non-financial relationships to declare.

More from Categories : Health & Fitness